Pharmaceutical Technology on MSN
Potentially “groundbreaking” FDA gene therapy pathway leaves key issues unresolved
A new FDA pathway could speed bespoke gene therapies, but key questions over scope and commercial viability remain.
The market offers strong growth potential driven by advancements in genetic engineering for efficient pharmaceutical protein ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback